Skip to main content
Premium Trial:

Request an Annual Quote

Geospiza and NuGen to Integrate and Co-Market Software, Sample Prep for Next-Gen Sequencing

Premium

Geospiza and NuGen Technologies said this week that they are developing a workflow for next-generation sequencing that will integrate their respective genetic analysis software and sample-prep technology.

Under a co-marketing agreement, the companies will combine Geospiza's GeneSifter software with NuGen's Ovation and Encore sample prep reagents.

The integrated workflow will enable researchers "to follow and document a step-by-step best practice for sample preparation combined with fully integrated data analysis and other sample information in one system," said Rob Arnold, Geospiza's president, in a statement.

Researchers at the Scripps Research Institute will be testing the new workflow.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.